WAVE Life Sciences

WVE · NASDAQ

$3.42+$0.25 (+7.89%)TodayMarket closed ·
Prev close $3.17

Who owns WVE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 54.3% of WVE’s shares.

  • RA Capital Management, LP14.0%
  • GSK plc9.5%
  • BlackRock Institutional Trust Company, N.A.7.2%
  • Maverick Capital, Ltd.5.3%
  • Next 6 largest institutions18.3%
  • All other shareholders45.7%
Top institutional holders of WVE
HolderShares% of shares
RA Capital Management, LP26.98M14.02%
GSK plc18.25M9.48%
BlackRock Institutional Trust Company, N.A.13.77M7.16%
Maverick Capital, Ltd.10.28M5.34%
Shin Nippon Biomedical Laboratories Ltd9.61M4.99%
Driehaus Capital Management, LLC5.44M2.83%
PRIMECAP Management Company5.35M2.78%
683 Capital Management LLC4.95M2.57%
Fidelity Management & Research Company LLC4.92M2.56%
State Street Investment Management (US)4.84M2.52%

Largest mutual fund holders

Top mutual fund holders of WVE
HolderShares% of shares
PRIMECAP Odyssey Aggressive Growth Fund4.11M2.14%
BB Biotech Fd4.09M2.13%
iShares Russell 2000 ETF3.58M1.86%
Vanguard Extended Market Index Fund1.75M0.91%
Fidelity Growth Company Fund1.66M0.86%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $135.07K (4 trades) of WVE on the open market, with no buys.

Latest WVE insider transactions
InsiderTypeSharesValue
Tan Aik NaAward64.00K—
Tan Aik NaAward10.70K—
TAKANASHI KENAward64.00K—
TAKANASHI KENAward10.70K—
Wagner Heidi LAward64.00K—
Wagner Heidi LAward10.70K—
Verdine Gregory L.Award64.00K—
Verdine Gregory L.Award10.70K—
Rawcliffe AdrianAward64.00K—
Rawcliffe AdrianAward10.70K—

Short interest

Settled Sep 30, 2026

Shares short
18.56M
Days to cover
5.70
% of shares outstanding
9.64%
Average daily volume
3.26M
Change since last report
+5.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.